Advances in Oncology, 2023: Advances, cartea 3-1
Editat de Leonidas C. Plataniasen Limba Engleză Hardback – 17 apr 2023
Din seria Advances
- 5%
Preț: 755.72 lei - 5%
Preț: 1379.27 lei - 5%
Preț: 1371.93 lei - 5%
Preț: 1270.91 lei - 5%
Preț: 935.64 lei - 5%
Preț: 688.28 lei - 5%
Preț: 1268.15 lei - 5%
Preț: 836.77 lei - 5%
Preț: 1273.77 lei - 5%
Preț: 1202.23 lei - 5%
Preț: 1202.23 lei - 5%
Preț: 1270.83 lei - 5%
Preț: 936.57 lei - 5%
Preț: 1196.72 lei - 5%
Preț: 961.79 lei - 5%
Preț: 1271.69 lei - 5%
Preț: 693.79 lei - 5%
Preț: 1202.23 lei - 5%
Preț: 1202.23 lei - 5%
Preț: 1203.15 lei - 5%
Preț: 1201.83 lei - 5%
Preț: 1202.23 lei - 5%
Preț: 1267.19 lei - 5%
Preț: 1266.25 lei - 5%
Preț: 1176.20 lei - 5%
Preț: 1272.48 lei - 5%
Preț: 1262.57 lei - 5%
Preț: 1269.02 lei - 5%
Preț: 1259.83 lei - 5%
Preț: 1266.25 lei - 5%
Preț: 1315.56 lei - 5%
Preț: 1264.45 lei - 5%
Preț: 1176.72 lei - 5%
Preț: 1172.52 lei - 24%
Preț: 773.58 lei - 24%
Preț: 703.63 lei - 5%
Preț: 858.59 lei - 5%
Preț: 872.05 lei - 24%
Preț: 619.57 lei - 24%
Preț: 699.43 lei - 24%
Preț: 744.40 lei - 24%
Preț: 772.08 lei - 24%
Preț: 830.27 lei - 24%
Preț: 848.94 lei - 24%
Preț: 903.22 lei - 24%
Preț: 847.13 lei - 29%
Preț: 914.92 lei - 24%
Preț: 704.28 lei - 24%
Preț: 848.07 lei
Preț: 1023.86 lei
Preț vechi: 1346.27 lei
-24%
Puncte Express: 1536
Carte tipărită la comandă
Livrare economică 20 octombrie-03 noiembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
Cuprins
SECTION I: RADIATION ONCOLOGY
1. De-escalation for Human Papillomavirus-Associated Oropharyngeal Cancer: A Comprehensive Review
2. Treatment of Endometrial Cancer: Updates and Future Directives
SECTION II: SURGICAL ONCOLOGY
3. Remote Telemonitoring and Telehealth in Surgical Oncology
4. Management of In-Transit Metastatic Melanoma
5. Contemporary Management of Merkel Cell Carcinoma
SECTION III: GYNECOLOGIC ONCOLOGY
6. Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets
7. Advances in Cervical Cancer
SECTION IV: PEDIATRIC ONCOLOGY
8. Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations
SECTION V: NEURO-ONCOLOGY
9. Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas
10. Updates on Role for and Efficacy of Laser Interstitial Thermal Therapy in the Management of Brain Tumors
11. The Microbiome and Central Nervous System Tumors
SECTION VI: HEMATOLOGICAL
12. ONCOLOGY Moving Toward a Chemotherapy-Free Approach for Philadelphia-Chromosome>Positive Acute Lymphoblastic Leukemia
13. Inherited Predisposition to Hematopoietic
14. Malignancies: Advances Made in the Diagnosis and Management of Hereditary Hematopoietic Malignancies in the Era of Next-Generation Sequencing Technologies
SECTION VII: URO-ONCOLOGY
15. The Future of Radioligand Therapies in Metastatic Castrate-Resistant Prostate Cancer
16. The Future of Antibody-Drug Conjugates in Urothelial Cancer: New Indications and Novel Targets
SECTION VIII: GASTROINTESTINAL
17. ONCOLOGY Targeting Rat Sarcoma Viral Oncogene Homolog for Treatment of Gastrointestinal Cancers
18. Recent Clinical Advances in Rare Gastrointestinal Tumors: Anal, Small Intestine, and Appendix Cancers
19. Gastrointestinal Cancers and the Link to the Microbiome
1. De-escalation for Human Papillomavirus-Associated Oropharyngeal Cancer: A Comprehensive Review
2. Treatment of Endometrial Cancer: Updates and Future Directives
SECTION II: SURGICAL ONCOLOGY
3. Remote Telemonitoring and Telehealth in Surgical Oncology
4. Management of In-Transit Metastatic Melanoma
5. Contemporary Management of Merkel Cell Carcinoma
SECTION III: GYNECOLOGIC ONCOLOGY
6. Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets
7. Advances in Cervical Cancer
SECTION IV: PEDIATRIC ONCOLOGY
8. Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations
SECTION V: NEURO-ONCOLOGY
9. Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas
10. Updates on Role for and Efficacy of Laser Interstitial Thermal Therapy in the Management of Brain Tumors
11. The Microbiome and Central Nervous System Tumors
SECTION VI: HEMATOLOGICAL
12. ONCOLOGY Moving Toward a Chemotherapy-Free Approach for Philadelphia-Chromosome>Positive Acute Lymphoblastic Leukemia
13. Inherited Predisposition to Hematopoietic
14. Malignancies: Advances Made in the Diagnosis and Management of Hereditary Hematopoietic Malignancies in the Era of Next-Generation Sequencing Technologies
SECTION VII: URO-ONCOLOGY
15. The Future of Radioligand Therapies in Metastatic Castrate-Resistant Prostate Cancer
16. The Future of Antibody-Drug Conjugates in Urothelial Cancer: New Indications and Novel Targets
SECTION VIII: GASTROINTESTINAL
17. ONCOLOGY Targeting Rat Sarcoma Viral Oncogene Homolog for Treatment of Gastrointestinal Cancers
18. Recent Clinical Advances in Rare Gastrointestinal Tumors: Anal, Small Intestine, and Appendix Cancers
19. Gastrointestinal Cancers and the Link to the Microbiome